Art

J-GLOBAL ID：201402234374895276   Reference number：14A0471805

Molecular status of pituitary carcinoma and atypical adenoma that contributes the effectiveness of temozolomide

テモゾロミドの有効性に関与する下垂体癌および異型腺腫の分子基盤

Author (20)： MATSUNO Akira (Teikyo Univ. Chiba Medical Center, Chiba, JPN) ,  MURAKAMI Mineko (Teikyo Univ. Chiba Medical Center, Chiba, JPN) ,  HOYA Katsumi (Teikyo Univ. Chiba Medical Center, Chiba, JPN) ,  YAMADA Shoko M. (Teikyo Univ. Chiba Medical Center, Chiba, JPN) ,  MIYAMOTO Shinya (Teikyo Univ. Chiba Medical Center, Chiba, JPN) ,  YAMADA So (Teikyo Univ. Chiba Medical Center, Chiba, JPN) ,  SON Jae-Hyun (Teikyo Univ. Chiba Medical Center, Chiba, JPN) ,  NISHIDO Hajime (Teikyo Univ. Chiba Medical Center, Chiba, JPN) ,  IDE Fuyuaki (Teikyo Univ. Chiba Medical Center, Chiba, JPN) ,  NAGASHIMA Hiroshi (Teikyo Univ. Chiba Medical Center, Chiba, JPN) ,  SUGAYA Mutsumi (Teikyo Univ. Chiba Medical Center, Chiba, JPN) ,  HIROHATA Toshio (Teikyo Univ. Chiba Medical Center, Chiba, JPN) ,  HIROHATA Toshio (Univ. Tokyo, Tokyo, JPN) ,  MIZUTANI Akiko (Teikyo Univ. Chiba Medical Center, Chiba, JPN) ,  MIZUTANI Akiko (Teikyo Heisei Univ., Tokyo, JPN) ,  OKINAGA Hiroko (Teikyo Heisei Univ., Tokyo, JPN) ,  ISHII Yudo (Nippon Medical School, Tokyo, JPN) ,  TAHARA Shigeyuki (Nippon Medical School, Tokyo, JPN) ,  TERAMOTO Akira (Nippon Medical School, Tokyo, JPN) ,  OSAMURA R. Yoshiyuki (International Univ. Health and Welfare Mita Hospital, Tokyo, JPN)
Material： Medical Molecular Morphology  (Med Mol Morphol)
Volume： 47  Issue： 1  Page： 1-7  Publication year： Mar. 2014 
JST Material Number： L1883A  ISSN： 1860-1480  Document type： Article
Article type： 文献レビュー  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： MSH6 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0471805&from=J-GLOBAL&jstjournalNo=L1883A") }}

JST classification (2)： Tumors(=neoplasms)of endocrine system  (GL04000P) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Substance index (1)： Temozolomide

Reference (83)：

• Kaltsas GA, Grossman AB (1998) Malignant pituitary tumours. Pituitary 1:69-81
• Ragel BT, Couldwell WT (2004) Pituitary carcinoma: a review of the literature. Neurosurg Focus 16:E7
• Landman RE, Horwith M, Peterson RE, Khandji AG, Wardlaw SL (2002) Long-term survival with ACTH-secreting carcinoma of the pituitary: a case report and review of the literature. J Clin Endocrinol Metab 87:3084-3089
• Lim S, Shahinian H, Maya MM, Yong W, Heaney AP (2006) Temozolomide: a novel treatment for pituitary carcinoma. Lancet Oncol 7:518-520
• Syro LV, Uribe H, Penagos LC, Ortiz LD, Fadul CE, Horvath E, Kovacs K (2006) Antitumour effects of temozolomide in a man with a large, invasive prolactin-producing pituitary neoplasm. Clin Endocrinol (Oxf) 65:552-553

Terms in the title (7)： テモゾロミド ,  有効性 ,  下垂体癌 ,  異型 ,  腺腫 ,  分子 ,  基盤